Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,550,698
+$1,008,664 QoQ
Shares Held
1,576,352
+2.3% QoQ
Ownership
1.87%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 172 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Derivatives in CRVS
reported options exposure · as of Dec 31, 2024CallValue
$2,675,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,870 across 359 Biotechnology names. CRVS ranks #105 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CRVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,550,698 | 1,576,352 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,542,034 | 1,540,809 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $3,284,587 | 445,670 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $680,844 | 170,211 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $2,675,000 | 500,000 | Call | Defined | 2025-02-11 | |
| 2024-12-31 | $3,127,321 | 584,546 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,640,000 | 500,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $1,985,918 | 376,121 | Shares | Defined | 2024-11-14 | |
| 2022-03-31 | $115,775 | 70,595 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $68,306 | 25,583 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $94,876 | 30,804 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $291,044 | 81,754 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $415,267 | 103,558 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $310,841 | 114,280 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $236,457 | 112,065 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||